JPWO2021025129A1 - - Google Patents

Info

Publication number
JPWO2021025129A1
JPWO2021025129A1 JP2021537387A JP2021537387A JPWO2021025129A1 JP WO2021025129 A1 JPWO2021025129 A1 JP WO2021025129A1 JP 2021537387 A JP2021537387 A JP 2021537387A JP 2021537387 A JP2021537387 A JP 2021537387A JP WO2021025129 A1 JPWO2021025129 A1 JP WO2021025129A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021537387A
Other languages
Japanese (ja)
Other versions
JP7597714B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021025129A1 publication Critical patent/JPWO2021025129A1/ja
Priority to JP2024207323A priority Critical patent/JP2025019313A/ja
Application granted granted Critical
Publication of JP7597714B2 publication Critical patent/JP7597714B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2021537387A 2019-08-07 2020-08-06 涙液分泌促進用眼科組成物 Active JP7597714B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024207323A JP2025019313A (ja) 2019-08-07 2024-11-28 涙液分泌促進用眼科組成物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2019145670 2019-08-07
JP2019145670 2019-08-07
JP2019239605 2019-12-27
JP2019239605 2019-12-27
PCT/JP2020/030231 WO2021025129A1 (ja) 2019-08-07 2020-08-06 涙液分泌促進用眼科組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024207323A Division JP2025019313A (ja) 2019-08-07 2024-11-28 涙液分泌促進用眼科組成物

Publications (2)

Publication Number Publication Date
JPWO2021025129A1 true JPWO2021025129A1 (https=) 2021-02-11
JP7597714B2 JP7597714B2 (ja) 2024-12-10

Family

ID=74503644

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021537387A Active JP7597714B2 (ja) 2019-08-07 2020-08-06 涙液分泌促進用眼科組成物
JP2024207323A Pending JP2025019313A (ja) 2019-08-07 2024-11-28 涙液分泌促進用眼科組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024207323A Pending JP2025019313A (ja) 2019-08-07 2024-11-28 涙液分泌促進用眼科組成物

Country Status (7)

Country Link
US (1) US20220280515A1 (https=)
EP (1) EP4011450A4 (https=)
JP (2) JP7597714B2 (https=)
KR (1) KR20220044288A (https=)
CN (2) CN118903144A (https=)
TW (1) TW202120094A (https=)
WO (1) WO2021025129A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119367282A (zh) * 2019-12-27 2025-01-28 乐敦制药株式会社 水性组合物
US20230285564A1 (en) * 2020-07-30 2023-09-14 Rohto Pharmaceutical Co., Ltd. Aqueous Composition
EP4176882A4 (en) * 2020-07-30 2024-01-10 Rohto Pharmaceutical Co., Ltd. AQUEOUS COMPOSITION
JP2025014078A (ja) * 2021-11-30 2025-01-29 興和株式会社 新規ニコチンアミド化合物及びその用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009046470A (ja) * 2007-07-11 2009-03-05 Pfizer Inc ドライアイ障害を治療する医薬組成物および方法
WO2011013785A1 (ja) * 2009-07-31 2011-02-03 日本たばこ産業株式会社 含窒素スピロ環化合物及びその医薬用途
WO2017006968A1 (ja) * 2015-07-07 2017-01-12 日本たばこ産業株式会社 ７Ｈ－ピロロ［２，３－ｄ］ピリミジン誘導体の製造方法及びその中間体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6427497B2 (ja) * 2013-10-21 2018-11-21 日本たばこ産業株式会社 眼疾患の治療剤又は予防剤
TWI790218B (zh) 2016-12-21 2023-01-21 日商日本煙草產業股份有限公司 7Ｈ－吡咯并[2,3－ｄ]嘧啶衍生物的製造方法及其共結晶
EP3559003B1 (en) * 2016-12-21 2022-08-24 Japan Tobacco Inc. Crystalline forms of a janus kinase inhibitor
CN119367282A (zh) * 2019-12-27 2025-01-28 乐敦制药株式会社 水性组合物
JP7722931B2 (ja) * 2019-12-27 2025-08-13 ロート製薬株式会社 水性組成物
US20230285564A1 (en) * 2020-07-30 2023-09-14 Rohto Pharmaceutical Co., Ltd. Aqueous Composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009046470A (ja) * 2007-07-11 2009-03-05 Pfizer Inc ドライアイ障害を治療する医薬組成物および方法
WO2011013785A1 (ja) * 2009-07-31 2011-02-03 日本たばこ産業株式会社 含窒素スピロ環化合物及びその医薬用途
WO2017006968A1 (ja) * 2015-07-07 2017-01-12 日本たばこ産業株式会社 ７Ｈ－ピロロ［２，３－ｄ］ピリミジン誘導体の製造方法及びその中間体

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
中村雅胤: "ドライアイ研究の最前線", 日薬理誌, vol. 135, JPN6020037693, 2010, pages 138 - 141, ISSN: 0005316652 *

Also Published As

Publication number Publication date
TW202120094A (zh) 2021-06-01
JP2025019313A (ja) 2025-02-06
WO2021025129A1 (ja) 2021-02-11
CN118903144A (zh) 2024-11-08
CN114173788A (zh) 2022-03-11
JP7597714B2 (ja) 2024-12-10
US20220280515A1 (en) 2022-09-08
EP4011450A4 (en) 2023-08-09
EP4011450A1 (en) 2022-06-15
KR20220044288A (ko) 2022-04-07

Similar Documents

Publication Publication Date Title
BR112019017762A2 (https=)
BR112021017339A2 (https=)
BR112021017637A2 (https=)
BR112021017892A2 (https=)
BR112021017782A2 (https=)
BR112021016821A2 (https=)
BR112021017939A2 (https=)
BR112021017738A2 (https=)
BR112021016996A2 (https=)
BR112021008711A2 (https=)
BR112019016141A2 (https=)
BR112021017728A2 (https=)
BR112021013944A2 (https=)
BR112021018452A2 (https=)
BR112021017703A2 (https=)
BR112019016142A2 (https=)
BR112021017732A2 (https=)
JPWO2021025129A1 (https=)
BR112021017234A2 (https=)
BR112021017355A2 (https=)
BR112021018093A2 (https=)
BR112021017173A2 (https=)
BR112021017083A2 (https=)
JPWO2021132598A1 (https=)
BR112021015080A2 (https=)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230726

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240507

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240702

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20241029

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20241128

R150 Certificate of patent or registration of utility model

Ref document number: 7597714

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150